XTLB short interest
XTL Biopharmaceuticals Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 6,050 |
|---|---|
| Change vs prior report | -1,122 (-15.6%) |
| Change over six months | +79.6% |
| Days to cover | 1.27 (sector: 3.78) |
| Average daily volume | 4,749 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
XTLB short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 6,050 | -15.6% | 1.27 | 4,749 |
| 2026-09-15 | 7,172 | -36.1% | 1.25 | 5,743 |
| 2026-08-31 | 11,229 | +2.1% | 1.00 | 14,673 |
| 2026-08-14 | 10,999 | -55.2% | 1.84 | 5,965 |
| 2026-07-31 | 24,556 | -32.1% | 6.97 | 3,523 |
| 2026-07-15 | 36,172 | +286.4% | 1.00 | 57,229 |
| 2026-06-30 | 9,362 | -24.0% | 1.00 | 342,910 |
| 2026-06-15 | 12,314 | +26.3% | 1.00 | 13,534 |
| 2026-05-29 | 9,750 | -49.3% | 1.00 | 26,934 |
| 2026-05-15 | 19,218 | -97.2% | 1.00 | 239,726 |
| 2026-04-30 | 680,467 | +10742.4% | 1.00 | 10,341,465 |
| 2026-04-15 | 6,276 | +86.3% | 1.00 | 7,506 |
| 2026-03-31 | 3,369 | -94.0% | 1.00 | 10,793 |
| 2026-03-13 | 55,641 | -16.4% | 1.92 | 28,931 |
| 2026-02-27 | 66,538 | +1.4% | 1.03 | 64,411 |
| 2026-02-13 | 65,629 | -69.1% | 1.00 | 69,341 |
| 2026-01-30 | 212,089 | -62.8% | 1.43 | 147,836 |
| 2026-01-15 | 570,310 | +2538.0% | 1.00 | 3,905,616 |
| 2025-12-31 | 21,619 | +66.9% | 1.00 | 72,801 |
| 2025-12-15 | 12,951 | +478.7% | 1.00 | 24,294 |
| 2025-11-28 | 2,238 | -81.5% | 1.00 | 35,846 |
| 2025-11-14 | 12,120 | -2.4% | 1.00 | 66,535 |
| 2025-10-31 | 12,421 | -79.3% | 1.00 | 120,344 |
| 2025-10-15 | 59,972 | +391.2% | 1.00 | 4,377,858 |
| 2025-09-30 | 12,209 | -29.7% | 2.53 | 4,817 |
import finzdata as yf
yf.Ticker("XTLB").short_interest # every report since 2017
yf.Client().short_interest(["XTLB"], start="2018-01-01")Healthcare short interest · XTLB price history · Who owns XTLB · All short interest